跳至主要内容
临床试验/JPRN-UMIN000013341
JPRN-UMIN000013341已完成4 期

Exploratory Study to Evaluate the Effect of Uninterrupted Anticoagulants in Catheter Ablation Procedure for Non-valvular Atrial Fibrillation - Comparison between Rivaroxaban and Warfarin - - A Study on Anticoagulant Therapy in Catheter Ablation for Atrial Fibrillation - Rivaroxaban vs. Warfarin : A Comparative Study

Keio University School of Medicine0 个研究点目标入组 200 人开始时间: 2014年3月5日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who fulfill at least one of the following criteria 1. Has a history of a prior stroke or TIA within 6 months before enrollment 2. Has a history of a major bleeding within 12 months before enrollment 3. Has had major surgery including CABG within 6 months before enrollment 4. Has a history of a MI within 2 months before catheter ablation procedure 5. Has a CrCl < 30 mL/min at screening 6. Has a diagnosis or clinical condition requiring use of dual anti-platelet therapy 7. Has contraindications of rivaroxaban or warfarin 8. Be a patient judged as "inappropriate" by an investigator

研究者

相似试验